Lv633
1950 积分 2025-06-16 加入
Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial
3个月前
已完结
Front_Immunol_2024_NSCLC_biomarker
5个月前
已完结
JTO_imaging_biomarker_radiomics
5个月前
已完结
Front_Immunol_2022_TME_ICI
5个月前
已完结
Cells_2022_Biomarker
5个月前
已完结
Cells_2022_NSCLC_biomarker
5个月前
已完结
Tumor_Immunology_Immunotherapy_NSCLC
5个月前
已完结
IRF4_NSCLC_biomarker
5个月前
已完结
Zhao_2024_IRF4_biomarker
5个月前
已完结
Chen_2025_Neoadjuvant
5个月前
已完结
皖公网安备34019202002308
